News

Rocket Pharma plunges after FDA clinical hold on mid-stage trial
Shares of Rocket Pharmaceuticals (NASDAQ:RCKT) lost ~62% in the premarket on Tuesday after the gene therapy developer ...
FDA halts Rocket Pharma's gene therapy trial as complications lead to patient death
The U.S. FDA has paused a mid-stage gene therapy trial by Rocket Pharmaceuticals after a patient suffered serious ...
Fierce Biotech9d
Rocket crashes as gene therapy patient dies, FDA imposes hold
The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...
Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) on Tuesday announced an update related to RP-A501, its investigational gene therapy ...
STAT9d
Participant in Rocket Pharmaceuticals gene therapy study dies
A patient in a Rocket Pharmaceuticals gene therapy trial for a rare heart condition has died, the company said.
CoreWeave, Rocket Pharmaceuticals, SoundHound: Trending Tickers
Barclays analysts downgraded CoreWeave (CRWV) to Equal Weight, raising valuation concerns. This is CoreWeave's first ...
Rocket Pharmaceuticals Shares Down as Trial Patient Dies of Complications
Rocket Pharmaceuticals shares fell sharply in premarket trading Tuesday after a trial for its investigational therapy for Danon disease was halted by regulators following the death of a patient that ...
These Analysts Slash Their Forecasts On Rocket Pharmaceuticals
Rocket Pharmaceuticals Inc RCKT announced an update Tuesday related to RP-A501, its investigational gene therapy for Danon ...
MedCity News9d
Death in Rocket Pharma Gene Therapy Study Puts Spotlight on Trial Change Intended to Improve Safety
A patient has died in a clinical trial evaluating a Rocket Pharmaceuticals gene therapy shortly after complications emerged that led the FDA to pause the study. An inquiry into the fatality is ...
Evercore ISI Downgrades Rocket Pharmaceuticals (RCKT) Stock, Slashes PT
On May 30, Evercore ISI downgraded Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT )’s stock from an “Outperform” rating to “In ...
Rocket Pharma Reports Patient Death In Rare Disease Gene Therapy Trial, FDA Puts Clinical Hold
Rocket Pharmaceuticals halted its Danon disease gene therapy trial after a patient death, with the FDA placing the study on ...
Morningstar10d
Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases, today announced an update ...